Clinical Trials Logo

Intractable Pain clinical trials

View clinical trials related to Intractable Pain.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00996983 Active, not recruiting - Pain Clinical Trials

Safety and Activity Study of Intrathecally Administered Ziconotide for Neuropathic Pain in Patients With Cancer

ZIDON
Start date: September 2009
Phase: Phase 2
Study type: Interventional

Neuropathic pain is difficult to control because it is only partially sensitive to opioid analgesics, and requires the addition of other therapies such as antidepressants and epileptics. Ziconotide is a drug that is used to treat neuropathic pain in patients who have had inadequate pain control with prior combination of medicines.